Samsara BioCapital, LLC is an institutional investment manager that files quarterly 13F reports with the SEC. As of Q4 2024, the fund manages $729M in reported equity holdings across 43 positions. Data sourced from SEC EDGAR 13F filings (CIK 1744967).